ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc. (ARYX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
aryx · pe ratio · data through Dec 31, 2009
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for ARYx Therapeutics, Inc. (ARYX) measures how much investors pay for each dollar of the company's trailing earnings. ARYX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1.21.
Source: FMP · /ratios-ttm · /analyst-estimates · 2009-12-31
PE Ratio History
2003 – 2009 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
ARYx Therapeutics, Inc.You ARYX | $0M | N/A | — | -$1.21 |
 Abattis Bioceuticals Corp. ATTBF | $0M | N/A | — | -$0.01 |
 Nutranomics, Inc. NNRX | $1M | N/A | — | -$0.00 |
 Naturally Splendid Enterprises Ltd. NSPDF | $1M | N/A | — | -$0.22 |
 Nunzia Pharmaceutical Company NUNZ | $0M | N/A | — | -$0.26 |
 Onassis Holdings Corp. ONSS | $0M | N/A | — | -$0.00 |
 OWC Pharmaceutical Research Corp. OWCP | $0M | N/A | — | -$0.07 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2009-12-31Latest FY2009 | — | $-1.21 | — | |
2008-12-31 FY2008 | — | $-1.65 | — | |
2007-12-31 FY2007 | — | $-2.93 | — | |
2006-12-31 FY2006 | — | $-26.84 | — | |
2005-12-31 FY2005 | — | $-30.73 | — | |
2004-12-31 FY2004 | — | $-24.27 | — | |
2003-12-31 FY2003 | — | $-16.67 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for ARYx Therapeutics, Inc. (ARYX) measures how much investors pay for each dollar of the company's trailing earnings. ARYX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1.21.
Frequently asked questions
ARYX pe ratio · 6 questionsARYX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$1.21. Data sourced from Financial Modeling Prep via ARYX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ARYx Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09